NeoGenomics ( NASDAQ:NEO ) Full Year 2024 Results Key Financial Results Revenue: US$660.6m (up 12% from FY 2023). Net... NeoGenomics Inc (NEO) reports robust revenue growth and improved margins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback